Activities per year
Abstract
Herein, we report the crystal structure of 2,7-dichlorofluorescein methyl ester (DCF-ME) and its fluorescence response to hydroxyapatite binding. The reported fluorophore is very selective for staining the bone matrix and provides turn-on fluorescence upon hydroxyapatite binding. The reported fluorophore can readily pass the cell membrane of the C2C12 cell line, and it is non-toxic for the cell line. The reported fluorophore DCF-ME may find applications in monitoring bone remodeling and microcalcification as an early diagnosis tool for breast cancer and age-related macular degeneration.
| Original language | English |
|---|---|
| Pages (from-to) | 1415-1421 |
| Journal | Molecular Systems Design & Engineering |
| Issue number | 11 |
| Early online date | 10 Oct 2022 |
| DOIs | |
| Publication status | Published - 01 Nov 2022 |
Keywords
- Materials Chemistry
- Industrial and Manufacturing Engineering
- Process Chemistry and Technology
- Energy Engineering and Power Technology
- Biomedical Engineering
- Chemical Engineering (miscellaneous)
- Chemistry (miscellaneous)
Fingerprint
Dive into the research topics of 'A 2,7-dichlorofluorescein derivative to monitor microcalcifications'. Together they form a unique fingerprint.Activities
- 1 Participation in conference
-
Budapest Biannual Calcification meeting
Lengyel, I. (Participant)
01 Oct 2023 → 03 Oct 2023Activity: Participating in or organising an event types › Participation in conference
Student theses
-
Metabolomic changes underpinning the development of sub-retinal pigment epithelial deposits in macular degeneration and Alzheimer's disease.
Brown, C. N. (Author), Lengyel, I. (Supervisor) & Green, B. (Supervisor), Dec 2023Student thesis: Doctoral Thesis › Doctor of Philosophy